DrReposER ID |
PDB |
Ligand |
Organism |
Macromolecule |
Pfam |
Res. |
Interface |
HETATM |
1AQ7_B_AG2B4 |
1aq7 |
AG2 DB08838(Agmatine) |
Bos taurus;Microcystisaeruginosa |
AERUGINOSIN 98-B;TRYPSIN |
PF00089(Trypsin)no annotation |
8 |
HIS A 57ASP A 189SER A 190GLN A 192SER A 195VAL A 213GLY A 216GLY A 226 |
AG2 B 4
|
1B23_R_CYSR976 |
1b23 |
CYS DB00151(L-Cysteine) |
Escherichia coli;Thermus aquaticus |
CYSTEINYL TRNA;ELONGATION FACTOR TU |
NonePF00009(GTP_EFTU_D3)PF03143(GTP_EFTU_D2)PF03144(GTP_EFTU) |
4 |
HIS P 67HIS P 273ARG P 274ASN P 285 |
CYS R 976
|
1B2H_A_ACTA518 |
1b2h |
ACT DB03166(Aceticacid) |
;Salmonellaenterica |
LYS-ORN-LYS;PERIPLASMICOLIGOPEPTIDE-BINDINGPROTEIN |
NonePF00496(SBP_bac_5) |
6 |
LYS B 3TYR A 245ASN A 247ASN A 366HIS A 371TRP A 397 |
ACT A 518
|
1DIT_P_2PPP1 |
1dit |
2PP DB00313(ValproicAcid) |
;Homo sapiens |
ALPHA-THROMBIN;PEPTIDE INHIBITORCVS995 |
PF00089(Trypsin)no annotation |
6 |
ASP P 2PRO P 3LEU H 99ILE H 174TRP H 215GLU H 217 |
2PP P 1
|
1FMO_E_ADNE351 |
1fmo |
ADN DB00640(Adenosine) |
Mus musculus;Oryctolaguscuniculus |
CAMP-DEPENDENTPROTEIN KINASE;HEAT STABLE RABBITSKELETAL MUSCLEINHIBITOR PROTEIN |
PF00069(Pkinase)PF02827(PKI) |
14 |
ARG I 18LEU E 49GLY E 50VAL E 57ALA E 70VAL E 104TYR E 122VAL E 123GLU E 127ASN E 171LEU E 173THR E 183ASP E 184PHE E 327 |
ADN E 351
|
1I7Z_A_COCA301 |
1i7z |
COC DB00907(Cocaine) |
Homo sapiens;Mus musculus |
CHIMERA OF IGGAMMA-1 CHAIN: HUMANCONSTANT REGION ANDMOUSE VARIABLEREGION;CHIMERA OF IG KAPPACHAIN: HUMANCONSTANT REGION ANDMOUSE VARIABLEREGION |
PF07654(C1-set)PF07686(V-set) |
13 |
TYR B 32HIS A 34TYR A 36TYR A 49LEU A 50LEU A 89SER A 91GLU B 93GLU A 93TYR B 95TRP A 96PRO B 98ASP B 101 |
COC A 301
|
1I7Z_C_COCC302 |
1i7z |
COC DB00907(Cocaine) |
Homo sapiens;Mus musculus |
CHIMERA OF IGGAMMA-1 CHAIN: HUMANCONSTANT REGION ANDMOUSE VARIABLEREGION;CHIMERA OF IG KAPPACHAIN: HUMANCONSTANT REGION ANDMOUSE VARIABLEREGION |
no annotation |
13 |
TYR C 30HIS C 34TYR C 36TYR C 49LEU C 50LEU C 89SER C 91GLU C 93GLU D 93TYR D 95TRP C 96PRO D 98ASP D 101 |
COC C 302
|
1K4T_D_TTCD990 |
1k4t |
TTC DB01030(Topotecan) |
;Homo sapiens |
DNA TOPOISOMERASE I |
PF01028(Topoisom_I)PF02919(Topoisom_I_N)PF14370(Topo_C_assoc)no annotation |
5 |
GLU A 356ARG A 364LYS A 532ASP A 533THR A 718 |
TTC D 990
|
1MCB_P_DHIP3 |
1mcb |
DHI DB00117(L-Histidine) |
;Homo sapiens |
IMMUNOGLOBULINLAMBDA DIMER MCG(LIGHT CHAIN);PEPTIDEN-ACETYL-L-GLN-D-PHE-L-HIS-D-PRO-OH |
NonePF07654(C1-set)PF07686(V-set) |
5 |
GLN P 1TYR A 34TYR A 51GLU A 52TYR B 93 |
DHI P 3
|
1MCL_P_DHIP1 |
1mcl |
DHI DB00117(L-Histidine) |
;Homo sapiens |
IMMUNOGLOBULINLAMBDA DIMER MCG(LIGHT CHAIN);N-ACETYL-D-HIS-L-PRO-OH |
NonePF07654(V-set)PF07686(C1-set) |
5 |
PRO P 2TYR A 51GLU A 52TYR B 93PHE A 99 |
DHI P 1
|
1MCN_P_DHIP1 |
1mcn |
DHI DB00117(L-Histidine) |
;Homo sapiens |
IMMUNOGLOBULINLAMBDA DIMER MCG(LIGHT CHAIN);PEPTIDEN-ACETYL-D-HIS-L-PRO-NH2 |
NonePF07654(V-set)PF07686(C1-set) |
3 |
PRO P 2TYR B 34PHE A 99 |
DHI P 1
|
1RFF_A_SPMA700 |
1rff |
SPM DB00127(Spermine) |
;Homo sapiens |
TOPOISOMERASEI-DERIVED PEPTIDE;TYROSYL-DNAPHOSPHODIESTERASE 1 |
PF06087(Tyr-DNA_phospho)no annotation |
4 |
ASN A 591TRP A 605VAL A 606TYR C 724 |
SPM A 700
|
1RFI_A_SPMA999 |
1rfi |
SPM DB00127(Spermine) |
;Homo sapiens |
TOPOISOMERASEI-DERIVED PEPTIDE;TYROSYL-DNAPHOSPHODIESTERASE 1 |
PF06087(Tyr-DNA_phospho)no annotation |
5 |
TRP A 590TRP A 605VAL A 606PRO A 607LYS C 724 |
SPM A 999
|
1RR8_A_TTCA100 |
1rr8 |
TTC DB01030(Topotecan) |
;Homo sapiens |
DNA TOPOISOMERASE I |
PF01028(Topoisom_I)PF02919(Topoisom_I_N)PF14370(Topo_C_assoc)no annotation |
5 |
GLU C 356ARG C 364LYS C 532ASP C 533THR C 718 |
TTC A 100
|
1RRJ_B_TTCB990 |
1rrj |
TTC DB01030(Topotecan) |
;Homo sapiens |
DNA TOPOISOMERASE I |
PF01028(Topoisom_I)PF02919(Topoisom_I_N)PF14370(Topo_C_assoc)no annotation |
5 |
GLU A 356ARG A 364LYS A 532ASP A 533THR A 718 |
TTC B 990
|
1STF_E_CCSE25 |
1stf |
CCS DB04339(Carbocisteine) |
Carica papaya;Homo sapiens |
PAPAIN;STEFIN B (CYSTATINB) |
PF00031(Cystatin)PF00112(Peptidase_C1) |
10 |
SER I 8GLY I 9GLN E 19GLY E 23SER E 24TRP E 26PHE E 28SER E 29HIS E 159ALA E 160 |
CCS E 25
|
1T03_P_TFOP822 |
1t03 |
TFO DB00300(Tenofovir) |
;Humanimmunodeficiencyvirus 1 |
POL POLYPROTEIN;SYNTHETICOLIGONUCLEOTIDEPRIMER |
PF00075(RNase_H)PF00078(RVT_1)PF06815(RVT_connect)PF06817(RVT_thumb)no annotation |
7 |
ASP A 110TYR A 183MET A 184ASP A 185ASP A 186LYS A 219HIS A 221 |
TFO P 822
|
1ZEA_A_DHIA6 |
1zea |
DHI DB00117(L-Histidine) |
;Mus musculus |
MONOCLONALANTI-CHOLERA TOXINIGG1 KAPPA ANTIBODY,H CHAIN;MONOCLONALANTI-CHOLERA TOXINIGG1 KAPPA ANTIBODY,L CHAIN;SHORT SYNTHETICD-AMINO ACID PEPTIDED2 |
NonePF07654(V-set)PF07686(C1-set) |
3 |
TRP H 50ARG H 95PHE L 96 |
DHI A 6
|
1ZEA_A_DVAA1 |
1zea |
DVA DB00161(L-Valine) |
;Mus musculus |
MONOCLONALANTI-CHOLERA TOXINIGG1 KAPPA ANTIBODY,H CHAIN;SHORT SYNTHETICD-AMINO ACID PEPTIDED2 |
NonePF07654(V-set)PF07686(C1-set) |
4 |
THR H 31TYR H 32SER H 96TRP H 100 |
DVA A 1
|
2AOF_C_FRDC305 |
2aof |
FRD DB00182(Amphetamine) |
;Humanimmunodeficiencyvirus 1 |
PEPTIDE INHIBITOR;POL POLYPROTEIN |
PF00077(RVP)no annotation |
15 |
ASP A 25GLY A 49PRO A 81ALA A 82ILE A 84LEU B 123ASP B 125PRO B 181ALA B 182ILE B 184ASN C 304LEU C 306GLN C 307SER C 308ARG C 309 |
FRD C 305
|
2AOH_C_FRDC305 |
2aoh |
FRD DB00182(Amphetamine) |
;Humanimmunodeficiencyvirus 1 |
PEPTIDE INHIBITOR;POL POLYPROTEIN |
PF00077(RVP)no annotation |
15 |
LEU A 23ASP A 25GLY A 49PRO A 81ALA A 82LEU B 123ASP B 125GLY B 149ALA B 182ILE B 184PHE C 303ASN C 304PRO C 306GLN C 307ILE C 308 |
FRD C 305
|
2AOI_C_FRDC305 |
2aoi |
FRD DB00182(Amphetamine) |
;Humanimmunodeficiencyvirus 1 |
PEPTIDE INHIBITOR;POL POLYPROTEIN |
PF00077(RVP)no annotation |
16 |
ASP A 25GLY A 49PRO A 81VAL A 82ILE A 84LEU B 123ASP B 125PRO B 181VAL B 182ILE B 184PRO C 302GLY C 303ASN C 304LEU C 306GLN C 307SER C 308 |
FRD C 305
|
2AOJ_C_FRDC305 |
2aoj |
FRD DB00182(Amphetamine) |
;Humanimmunodeficiencyvirus 1 |
PEPTIDE INHIBITOR;POL POLYPROTEIN |
PF00077(RVP)no annotation |
17 |
LEU A 23ASP A 25GLY A 49PRO A 81VAL A 82LEU B 123ASP B 125GLY B 149ILE B 150PRO B 181VAL B 182ILE B 184PHE C 303ASN C 304PRO C 306GLN C 307ILE C 308 |
FRD C 305
|
2JFA_A_RALA600 |
2jfa |
RAL DB00481(Raloxifene) |
Homo sapiens;syntheticconstruct |
COREPRESSOR PEPTIDE;ESTROGEN RECEPTOR |
PF00104(Hormone_recep)no annotation |
19 |
ASP P 1LEU P 5MET A 343LEU A 346THR A 347ALA A 350ASP A 351GLU A 353LEU A 354TRP A 383LEU A 387MET A 388LEU A 391ARG A 394MET A 421ILE A 424LEU A 428HIS A 524LEU A 525 |
RAL A 600
|
2JFA_B_RALB600 |
2jfa |
RAL DB00481(Raloxifene) |
Homo sapiens;syntheticconstruct |
COREPRESSOR PEPTIDE;ESTROGEN RECEPTOR |
PF00104(Hormone_recep)no annotation |
17 |
LEU Q 5MET B 343LEU B 346THR B 347ALA B 350ASP B 351GLU B 353LEU B 354TRP B 383LEU B 387LEU B 391ARG B 394MET B 421ILE B 424GLY B 521HIS B 524LEU B 525 |
RAL B 600
|
2LJC_A_RIMA1 |
2ljc |
RIM DB00478(Rimantadine) |
Influenza Avirus;Influenza B virus |
M2 PROTEIN, BM2PROTEIN CHIMERA |
PF00599(Flu_M2)PF04772(Flu_B_M2)no annotation |
10 |
VAL B 27VAL D 27VAL A 27ALA B 30ALA C 30ALA D 30ALA A 30SER D 31SER A 31SER C 31 |
RIM A 1
|
2M9P_B_BEZB251 |
2m9p |
BEZ DB03793(BenzoicAcid) |
;Dengue virus |
SERINE PROTEASEINHIBITOR;SERINE PROTEASESUBUNIT NS2B, SERINEPROTEASE NS3 |
NonePF00949(Flavi_NS2B)PF01002(Peptidase_S7) |
3 |
VAL A 216SER A 219GLY A 220 |
BEZ B 251
|
2M9Q_B_BEZB251 |
2m9q |
BEZ DB03793(BenzoicAcid) |
;Dengue virus |
SERINE PROTEASEINHIBITOR;SERINE PROTEASESUBUNIT NS2B, SERINEPROTEASE NS3 |
NonePF00949(Flavi_NS2B)PF01002(Peptidase_S7) |
9 |
LEU A 6ILE A 86ILE A 97PHE A 107THR A 109VAL A 113THR A 114ALA A 117LEU A 119 |
BEZ B 251
|
2O5Y_H_STRH249 |
2o5y |
STR DB00396(Progesterone) |
Homo sapiens;Mus musculus |
CHIMERIC ANTIBODYFAB 1E9-DB3 |
PF07654(C1-set)PF07686(V-set) |
7 |
ASN H 35TRP H 50SER L 91GLY H 95THR H 97MET H 100TRP H 100 |
STR H 249
|
2Q6F_C_010C6 |
2q6f |
010 DB06770(Benzylalcohol) |
Aviancoronavirus;syntheticconstruct |
INFECTIOUSBRONCHITIS VIRUS(IBV) MAIN PROTEASE;N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE |
None |
3 |
ASN B 25LEU B 27HIS B 41 |
010 C 6
|
2XAD_E_GCSE710 |
2xad |
GCS DB01296(Glucosamine) |
Actinoplanesteichomyceticus;Nonomuraeagerenzanensis |
N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASE;TEICOPLANIN |
PF02585(PIG-L)no annotation |
8 |
HIS A 16TRP A 63ARG A 75ASP A 97SER A 98ILE A 99HIS A 161ASP A 163 |
GCS E 710
|
2XAD_F_GCSF710 |
2xad |
GCS DB01296(Glucosamine) |
Actinoplanesteichomyceticus;Nonomuraeagerenzanensis |
N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASE;TEICOPLANIN |
no annotation |
8 |
HIS B 16TRP B 63ARG B 75ASP B 97SER B 98ILE B 99HIS B 161ASP B 163 |
GCS F 710
|
2XAD_G_GCSG710 |
2xad |
GCS DB01296(Glucosamine) |
Actinoplanesteichomyceticus;Nonomuraeagerenzanensis |
N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASE;TEICOPLANIN |
no annotation |
8 |
HIS C 16TRP C 63ARG C 75ASP C 97SER C 98ILE C 99HIS C 161ASP C 163 |
GCS G 710
|
2XAD_H_GCSH710 |
2xad |
GCS DB01296(Glucosamine) |
Actinoplanesteichomyceticus;Nonomuraeagerenzanensis |
N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASE;TEICOPLANIN |
no annotation |
8 |
HIS D 16TRP D 63ARG D 75ASP D 97SER D 98ILE D 99HIS D 161ASP D 163 |
GCS H 710
|
2XCT_G_CPFG1020 |
2xct |
CPF DB00537(Ciprofloxacin) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITB, DNA GYRASESUBUNIT A |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
3 |
ARG B 458GLY B 459SER B1084 |
CPF G1020
|
2XCT_H_CPFH1020 |
2xct |
CPF DB00537(Ciprofloxacin) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITB, DNA GYRASESUBUNIT A |
no annotation |
3 |
ARG D 458GLU D 477SER D1084 |
CPF H1020
|
2XCT_X_CPFX1020 |
2xct |
CPF DB00537(Ciprofloxacin) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITB, DNA GYRASESUBUNIT A |
no annotation |
4 |
ARG S 458GLY S 459GLU S 477SER U1084 |
CPF X1020
|
2XKK_E_MFXE1100 |
2xkk |
MFX DB00218(Moxifloxacin) |
Acinetobacterbaumannii;syntheticconstruct |
DNA;TOPOISOMERASE IV |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
3 |
GLU C 437SER C1084ARG A1123 |
MFX E1100
|
3CB8_A_SAMA501 |
3cb8 |
SAM DB00118(S-Adenosylmethionine) |
;Escherichia coli |
PYRUVATEFORMATE-LYASE1-ACTIVATING ENZYME;PEPTIDE SUBSTRATEVSGYAV |
NonePF04055(Radical_SAM) |
15 |
TYR A 35HIS A 37ASN A 38SER A 76GLU A 79ASP A 104ASN A 106ASP A 129LYS A 131ARG A 166VAL A 168LEU A 199TYR A 201HIS A 202GLY B 734 |
SAM A 501
|
3D4S_A_TIMA401 |
3d4s |
TIM DB00373(Timolol) |
Escherichia virusT4;Homo sapiens |
BETA-2 ADRENERGICRECEPTOR/T4-LYSOZYMECHIMERA |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
15 |
TRP A 109THR A 110ASP A 113VAL A 114VAL A 117THR A 118SER A 203SER A 207TRP A 286PHE A 289PHE A 290ASN A 293TYR A 308ASN A 312TYR A 316 |
TIM A 401
|
3FOF_F_MFXF0 |
3fof |
MFX DB00218(Moxifloxacin) |
;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT A |
no annotation |
3 |
GLY B 77SER B 79SER B 80 |
MFX F 0
|
3FOF_H_MFXH0 |
3fof |
MFX DB00218(Moxifloxacin) |
;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT A;DNA TOPOISOMERASE 4SUBUNIT B |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
4 |
GLY A 77SER A 79SER A 80ARG C 456 |
MFX H 0
|
3IWM_G_010G6 |
3iwm |
010 DB06770(Benzylalcohol) |
Severe acuterespiratorysyndrome-relatedcoronavirus;syntheticconstruct |
3C-LIKE PROTEINASE;N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE |
None |
4 |
THR C 25LEU C 27MET C 49ASN C 142 |
010 G 6
|
3J7Z_A_ERYA9000 |
3j7z |
ERY DB00199(Erythromycin) |
Escherichia coli;Staphylococcusaureus |
23S RRNA;50S RIBOSOMALPROTEIN L22;ERMCL NASCENT CHAIN |
PF00237(Ribosomal_L22)PF08253(Leader_Erm) |
3 |
ILE a 81PHE a 82LYS S 90 |
ERY A9000
|
3K9F_F_LFXF0 |
3k9f |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT A;DNA TOPOISOMERASE 4SUBUNIT B |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
5 |
SER A 79ARG B 117ARG C 456GLY C 457GLU C 475 |
LFX F 0
|
3K9F_H_LFXH0 |
3k9f |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT A;DNA TOPOISOMERASE 4SUBUNIT B |
PF00521(DNA_topoisoIV)no annotation |
6 |
SER B 79ARG A 117ARG D 456GLY D 457GLU D 474GLU D 475 |
LFX H 0
|
3NYA_A_JTZA1203 |
3nya |
JTZ DB00866(Alprenolol) |
Escherichia virusT4;Homo sapiens |
BETA-2 ADRENERGICRECEPTOR, LYSOZYME |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
14 |
TRP A 109THR A 110ASP A 113VAL A 114VAL A 117THR A 118SER A 203SER A 207TRP A 286PHE A 289PHE A 290ASN A 293ASN A 312TYR A 316 |
JTZ A1203
|
3PQZ_L_CCSL11 |
3pqz |
CCS DB04339(Carbocisteine) |
;Homo sapiens |
GROWTH FACTORRECEPTOR-BOUNDPROTEIN 7;CYCLIC PEPTIDE |
None |
4 |
TRP L 1PHE L 9PRO L 10LEU D 481 |
CCS L 11
|
3PQZ_M_CCSM11 |
3pqz |
CCS DB04339(Carbocisteine) |
;Homo sapiens |
GROWTH FACTORRECEPTOR-BOUNDPROTEIN 7;CYCLIC PEPTIDE |
None |
4 |
TRP M 1PHE M 9PRO M 10LEU C 481 |
CCS M 11
|
3QEL_B_QELB1 |
3qel |
QEL DB08954(Ifenprodil) |
Rattusnorvegicus;Xenopus laevis |
GLUTAMATE [NMDA]RECEPTOR SUBUNITEPSILON-2;NMDA GLUTAMATERECEPTOR SUBUNIT |
PF01094(ANF_receptor) |
11 |
ALA B 107TYR A 109GLN B 110THR A 110ILE B 111PHE B 114ARG A 115LEU A 135THR B 174PRO B 177GLU B 236 |
QEL B 1
|
3QEL_D_QELD2 |
3qel |
QEL DB08954(Ifenprodil) |
Rattusnorvegicus;Xenopus laevis |
GLUTAMATE [NMDA]RECEPTOR SUBUNITEPSILON-2;NMDA GLUTAMATERECEPTOR SUBUNIT |
no annotation |
14 |
PRO D 78ALA D 107TYR C 109GLN D 110THR C 110ILE D 111PHE C 113PHE D 114ARG C 115LEU C 135THR D 174PHE D 176PRO D 177GLU D 236 |
QEL D 2
|
3QX3_D_EVPD1 |
3qx3 |
EVP DB00773(Etoposide) |
;Homo sapiens |
DNA TOPOISOMERASE2-BETA |
no annotation |
5 |
GLY B 478ASP B 479ARG B 503GLN B 778MET B 782 |
EVP D 1
|
3RAE_F_LFXF101 |
3rae |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT A;DNA TOPOISOMERASE 4SUBUNIT B |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
4 |
SER A 79ARG C 456GLY C 457GLU C 474 |
LFX F 101
|
3RAE_H_LFXH101 |
3rae |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT A;DNA TOPOISOMERASE 4SUBUNIT B |
no annotation |
5 |
SER B 79ARG D 456GLY D 457GLU D 474GLU D 475 |
LFX H 101
|
3RZE_A_D7VA1201 |
3rze |
D7V DB01142(Doxepin) |
Escherichia virusT4;Homo sapiens |
HISTAMINE H1RECEPTOR, LYSOZYMECHIMERA |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
13 |
ASP A 107TYR A 108SER A 111THR A 112ILE A 115TRP A 158THR A 194ASN A 198TRP A 428TYR A 431PHE A 432PHE A 435TYR A 458 |
D7V A1201
|
3S7F_A_SAMA1000 |
3s7f |
SAM DB00118(S-Adenosylmethionine) |
;Homo sapiens |
N-LYSINEMETHYLTRANSFERASESMYD2;P53 PEPTIDE |
NonePF00856(SET) |
12 |
LYS A 17ARG A 19GLU A 135HIS A 137CYS A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260LYS I 370 |
SAM A1000
|
3UF8_A_FK5A114 |
3uf8 |
FK5 DB00864(Tacrolimus) |
Burkholderiapseudomallei;Saccharomycescerevisiae |
UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE |
PF00254(FKBP_C)PF11976(Rad60-SLD) |
10 |
TYR A 33ASP A 44ARG A 49PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 |
FK5 A 114
|
3UPR_A_1KXA277 |
3upr |
1KX DB01048(Abacavir) |
;Homo sapiens |
HLA CLASS IHISTOCOMPATIBILITYANTIGEN, B-57 ALPHACHAIN;PEP-V |
PF00129(MHC_I)PF07654(C1-set)no annotation |
14 |
ILE P 3TYR P 5LEU P 7VAL P 9TYR A 9TYR A 74ILE A 95VAL A 97TYR A 99ASP A 114SER A 116TYR A 123ILE A 124TRP A 147 |
1KX A 277
|
3UPR_C_1KXC277 |
3upr |
1KX DB01048(Abacavir) |
;Homo sapiens |
HLA CLASS IHISTOCOMPATIBILITYANTIGEN, B-57 ALPHACHAIN;PEP-V |
no annotation |
13 |
ILE Q 3LEU Q 7VAL Q 9TYR C 9TYR C 74ILE C 95VAL C 97TYR C 99ASP C 114SER C 116TYR C 123ILE C 124TRP C 147 |
1KX C 277
|
3UQA_A_FK5A114 |
3uqa |
FK5 DB00864(Tacrolimus) |
Burkholderiapseudomallei;Saccharomycescerevisiae |
UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE |
PF00254(FKBP_C)PF11976(Rad60-SLD) |
10 |
TYR A 33ASP A 44ARG A 49PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 |
FK5 A 114
|
3UQB_A_FK5A114 |
3uqb |
FK5 DB00864(Tacrolimus) |
Burkholderiapseudomallei;Saccharomycescerevisiae |
UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE |
PF00254(FKBP_C)PF11976(Rad60-SLD) |
8 |
TYR A 33PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 |
FK5 A 114
|
3VAW_A_FK5A114 |
3vaw |
FK5 DB00864(Tacrolimus) |
Burkholderiapseudomallei;Saccharomycescerevisiae |
UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE |
PF00254(FKBP_C)PF11976(Rad60-SLD) |
11 |
TYR A 33ASP A 44ARG A 49PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ARG A 92ILE A 98PHE A 106 |
FK5 A 114
|
3VW7_A_VPXA2001 |
3vw7 |
VPX DB09030(Vorapaxar) |
Escherichia virusT4;Homo sapiens |
PROTEINASE-ACTIVATEDRECEPTOR 1, LYSOZYME |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
16 |
TYR A 183TYR A 187PRO A 236LEU A 237HIS A 255LEU A 258LEU A 262PHE A 271LEU A 332LEU A 333HIS A 336TYR A 337LEU A 340ALA A 349ALA A 352TYR A 353 |
VPX A2001
|
3VWP_A_ACAA503 |
3vwp |
ACA DB00513(AminocaproicAcid) |
Flavobacteriumsp. K172;Flavobacteriumsp. KI723T1 |
6-AMINOHEXANOATE-DIMER HYDROLASE |
PF00144(Beta-lactamase) |
10 |
MET A 111ALA A 112LYS A 115ASP A 181TRP A 186TYR A 215SER A 217ASN A 266GLY A 344ILE A 345 |
ACA A 503
|
3VWQ_A_ACAA601 |
3vwq |
ACA DB00513(AminocaproicAcid) |
Flavobacteriumsp. K172;Flavobacteriumsp. KI723T1 |
6-AMINOHEXANOATE-DIMER HYDROLASE |
PF00144(Beta-lactamase) |
12 |
MET A 111ALA A 112LYS A 115TYR A 170ASP A 181TRP A 186TYR A 215SER A 217PHE A 264ASN A 266GLY A 344ILE A 345 |
ACA A 601
|
3VWR_A_ACAA601 |
3vwr |
ACA DB00513(AminocaproicAcid) |
Flavobacteriumsp. K172;Flavobacteriumsp. KI723T1 |
6-AMINOHEXANOATE-DIMER HYDROLASE |
PF00144(Beta-lactamase) |
11 |
MET A 111ALA A 112LYS A 115ASP A 181TRP A 186TYR A 215SER A 217PHE A 264ASN A 266GLY A 344ILE A 345 |
ACA A 601
|
4APJ_A_ACTA1635 |
4apj |
ACT DB03166(Aceticacid) |
Gloydiusblomhoffii;Homo sapiens |
ANGIOTENSIN-CONVERTING ENZYME;BRADYKININ-POTENTIATING PEPTIDE B |
NonePF01401(Peptidase_M2) |
6 |
PRO P 11HIS A 383HIS A 387GLU A 411ASP A 415SER A 526 |
ACT A1635
|
4DAJ_A_0HKA2000 |
4daj |
0HK DB01409(Tiotropium) |
Escherichia virusT4;Rattus norvegicus |
MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
13 |
ASP A 147TYR A 148SER A 151ASN A 152TRP A 199THR A 231ALA A 238PHE A 239TRP A 503TYR A 506ASN A 507TYR A 529CYS A 532 |
0HK A2000
|
4DAJ_B_0HKB2000 |
4daj |
0HK DB01409(Tiotropium) |
Escherichia virusT4;Rattus norvegicus |
MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME |
no annotation |
15 |
ASP B 147TYR B 148SER B 151ASN B 152TRP B 199LEU B 225THR B 231THR B 234ALA B 238PHE B 239TRP B 503TYR B 506ASN B 507TYR B 529CYS B 532 |
0HK B2000
|
4DAJ_C_0HKC2000 |
4daj |
0HK DB01409(Tiotropium) |
Escherichia virusT4;Rattus norvegicus |
MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME |
no annotation |
13 |
ASP C 147TYR C 148SER C 151ASN C 152TRP C 199THR C 231THR C 234PHE C 239TRP C 503TYR C 506ASN C 507TYR C 529CYS C 532 |
0HK C2000
|
4DAJ_D_0HKD2000 |
4daj |
0HK DB01409(Tiotropium) |
Escherichia virusT4;Rattus norvegicus |
MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME |
no annotation |
13 |
ASP D 147TYR D 148SER D 151ASN D 152TRP D 199THR D 231THR D 234PHE D 239TRP D 503TYR D 506ASN D 507TYR D 529CYS D 532 |
0HK D2000
|
4EAH_A_ACTA1002 |
4eah |
ACT DB03166(Aceticacid) |
Mus musculus;Oryctolaguscuniculus |
ACTIN, ALPHASKELETAL MUSCLE;FORMIN-LIKE PROTEIN3 |
NonePF02181(FH2) |
5 |
GLN G 121GLU G 125THR G 126THR E 612ARG A 804 |
ACT A1002
|
4EAH_C_ACTC1002 |
4eah |
ACT DB03166(Aceticacid) |
Mus musculus;Oryctolaguscuniculus |
ACTIN, ALPHASKELETAL MUSCLE;FORMIN-LIKE PROTEIN3 |
None |
4 |
GLN H 121GLU H 125THR H 126ARG C 804 |
ACT C1002
|
4EAH_E_ACTE1001 |
4eah |
ACT DB03166(Aceticacid) |
Mus musculus;Oryctolaguscuniculus |
ACTIN, ALPHASKELETAL MUSCLE;FORMIN-LIKE PROTEIN3 |
NonePF00022(Actin)PF02181(FH2) |
4 |
GLN D 121GLU D 125THR A 612ARG E 804 |
ACT E1001
|
4EAH_F_ACTF401 |
4eah |
ACT DB03166(Aceticacid) |
Mus musculus;Oryctolaguscuniculus |
ACTIN, ALPHASKELETAL MUSCLE;FORMIN-LIKE PROTEIN3 |
None |
4 |
GLN F 121GLU F 125THR C 612ARG B 804 |
ACT F 401
|
4G0U_F_ASWF101 |
4g0u |
ASW DB00276(Amsacrine) |
;Homo sapiens |
DNA TOPOISOMERASE2-BETA |
PF00521(DNA_topoisoIV)PF01751(Toprim)PF16898(TOPRIM_C)no annotation |
6 |
PRO A 455ARG A 503GLY A 504ALA A 521GLU A 522GLN A 778 |
ASW F 101
|
4G0V_D_MIXD101 |
4g0v |
MIX DB01204(Mitoxantrone) |
;Homo sapiens |
DNA TOPOISOMERASE2-BETA |
no annotation |
6 |
ARG B 503GLY B 504ASN B 520GLU B 522GLN B 778MET B 782 |
MIX D 101
|
4I13_A_FOLA201 |
4i13 |
FOL DB00158(FolicAcid) |
Escherichia coli;Lama glama |
DIHYDROFOLATEREDUCTASE;PROTEIN CA1697(NANOBODY) |
PF00186(DHFR_1)PF07686(V-set) |
16 |
ILE A 5ALA A 7GLU A 17ASP A 27LEU A 28TRP A 30PHE A 31LYS A 32THR A 46ILE A 50LEU A 54ARG A 57ILE A 94TYR A 100ARG B 104THR A 113 |
FOL A 201
|
4IAQ_A_2GMA2001 |
4iaq |
2GM DB00320(Dihydroergotamine) |
Escherichia coli;Homo sapiens |
CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 1B AND E.COLI SOLUBLECYTOCHROME B562 |
PF00001(7tm_1)PF07361(Cytochrom_B562) |
18 |
TRP A 125LEU A 126ASP A 129ILE A 130CYS A 133THR A 134VAL A 200VAL A 201SER A 212ALA A 216TRP A 327PHE A 330PHE A 331MET A 337LEU A 348PHE A 351ASP A 352THR A 355 |
2GM A2001
|
4IAR_A_ERMA2001 |
4iar |
ERM DB00696(Ergotamine) |
Escherichia coli;Homo sapiens |
CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 1B AND E.COLI SOLUBLECYTOCHROME B562 |
PF00001(7tm_1)PF07361(Cytochrom_B562) |
19 |
TRP A 125LEU A 126ASP A 129ILE A 130CYS A 133THR A 134VAL A 200VAL A 201SER A 212ALA A 216TRP A 327PHE A 330PHE A 331SER A 334MET A 337LEU A 348PHE A 351ASP A 352THR A 355 |
ERM A2001
|
4IB4_A_ERMA2001 |
4ib4 |
ERM DB00696(Ergotamine) |
Escherichia coli;Homo sapiens |
CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 |
PF00001(7tm_1)PF07361(Cytochrom_B562) |
19 |
LEU A 132ASP A 135VAL A 136SER A 139THR A 140VAL A 208LEU A 209LYS A 211MET A 218ALA A 225TRP A 337PHE A 340PHE A 341ASN A 344LEU A 347VAL A 348GLN A 359LEU A 362VAL A 366 |
ERM A2001
|
4JUO_F_LFXF101 |
4juo |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT A;DNA TOPOISOMERASE 4SUBUNIT B;E-SITE DNA |
PF00204(DNA_gyraseB)PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)PF02518(HATPase_c)no annotation |
4 |
SER A 79ARG C 456GLY C 457GLU C 474 |
LFX F 101
|
4K38_A_SAMA504 |
4k38 |
SAM DB00118(S-Adenosylmethionine) |
;Clostridiumperfringens |
ANAEROBICSULFATASE-MATURATINGENZYME;KP18CYS PEPTIDE |
NonePF04055(Radical_SAM)PF13186(SPASM) |
12 |
CYS D 7TYR A 21TYR A 24GLN A 64GLU A 67GLN A 98SER A 122ARG A 134LEU A 163VAL A 165ILE A 192LEU A 195 |
SAM A 504
|
4K38_B_SAMB504 |
4k38 |
SAM DB00118(S-Adenosylmethionine) |
;Clostridiumperfringens |
ANAEROBICSULFATASE-MATURATINGENZYME;KP18CYS PEPTIDE |
None |
14 |
CYS C 7TYR B 21CYS B 22PHE B 23TYR B 24GLN B 64GLU B 67GLN B 98SER B 122ARG B 134LEU B 163VAL B 165ILE B 192LEU B 195 |
SAM B 504
|
4K39_A_SAMA504 |
4k39 |
SAM DB00118(S-Adenosylmethionine) |
;Clostridiumperfringens |
ANAEROBICSULFATASE-MATURATINGENZYME;CP18CYS PEPTIDE |
NonePF04055(SPASM)PF13186(Radical_SAM) |
13 |
CYS C 7TYR A 21PHE A 23TYR A 24GLU A 67GLN A 98ASN A 100SER A 122ARG A 134LEU A 163VAL A 165ILE A 192LEU A 195 |
SAM A 504
|
4K50_B_ACTB701 |
4k50 |
ACT DB03166(Aceticacid) |
;Rhinovirus A |
RNA (33-MER);RNA POLYMERASE3D-POL |
NonePF00680(RdRP_1) |
3 |
HIS A 199GLY A 291ILE A 294 |
ACT B 701
|
4K50_F_ACTF701 |
4k50 |
ACT DB03166(Aceticacid) |
;Rhinovirus A |
RNA (33-MER);RNA POLYMERASE3D-POL |
None |
4 |
PHE E 195HIS E 199GLY E 291ILE E 294 |
ACT F 701
|
4K50_J_ACTJ701 |
4k50 |
ACT DB03166(Aceticacid) |
;Rhinovirus A |
RNA (33-MER);RNA POLYMERASE3D-POL |
None |
3 |
HIS I 199GLY I 291ILE I 294 |
ACT J 701
|
4KOE_F_TR6F101 |
4koe |
TR6 DB00685(Trovafloxacin) |
;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT A;DNA TOPOISOMERASE 4SUBUNIT B;E-SITE DNA2 |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
6 |
SER A 79ARG B 117GLY C 434ASP C 435ARG C 456GLY C 457 |
TR6 F 101
|
4KOE_H_TR6H101 |
4koe |
TR6 DB00685(Trovafloxacin) |
;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT A;DNA TOPOISOMERASE 4SUBUNIT B;E-SITE DNA4 |
PF00521(DNA_topoisoIV)no annotation |
7 |
SER B 79ARG A 117GLY D 434ASP D 435ARG D 456GLY D 457GLU D 475 |
TR6 H 101
|
4L6V_1_PQN12001 |
4l6v |
PQN DB01022(Phylloquinone) |
Bacillussubtilis;Synechocystis sp.PCC 6803 |
FUSION PROTEIN OFPHOTOSYSTEM ISUBUNIT III ANDSUBUNIT IX;PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 |
PF00223(PsaA_PsaB)PF01701(PSI_PsaJ)PF02507(PSI_PsaF) |
11 |
ALA 6 11TRP 1 49MET 1 684PHE 1 685SER 1 688GLY 1 689ARG 1 690TRP 1 693ALA 1 717LEU 1 718GLY 1 723 |
PQN 12001
|
4L6V_A_PQNA2001 |
4l6v |
PQN DB01022(Phylloquinone) |
Bacillussubtilis;Synechocystis sp.PCC 6803 |
FUSION PROTEIN OFPHOTOSYSTEM ISUBUNIT III ANDSUBUNIT IX;PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1 |
no annotation |
9 |
ALA f 11TRP a 49MET a 684PHE a 685SER a 688TRP a 693ALA a 717LEU a 718GLY a 723 |
PQN a2001
|
4LDO_A_ALEA1402 |
4ldo |
ALE DB00668(Epinephrine) |
Escherichia virusT4;Homo sapiens |
LYSOZYME, BETA-2ADRENERGIC RECEPTOR |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
10 |
ASP A1113VAL A1114VAL A1117PHE A1193SER A1203SER A1207PHE A1289ASN A1293ASN A1312TYR A1316 |
ALE A1402
|
4M7K_H_ACTH302 |
4m7k |
ACT DB03166(Aceticacid) |
Homo sapiens;Mus musculus |
10H10 HEAVY CHAIN |
PF07654(V-set)PF07686(C1-set) |
5 |
VAL H 2TYR H 27ARG H 98TYR H 101TYR H 109 |
ACT H 302
|
4MA3_L_ACTL301 |
4ma3 |
ACT DB03166(Aceticacid) |
Homo sapiens;Oryctolaguscuniculus |
C2095 HEAVY CHAIN;C2095 LIGHT CHAIN |
None |
3 |
PRO H 32ASN H 34HIS L 101 |
ACT L 301
|
4MBS_A_MRVA1101 |
4mbs |
MRV DB04835(Maraviroc) |
Clostridiumpasteurianum;Homo sapiens |
CHIMERA PROTEIN OFC-C CHEMOKINERECEPTOR TYPE 5 ANDRUBREDOXIN |
PF00001(7tm_1)PF00301(Rubredoxin) |
19 |
TYR A 37TRP A 86TYR A 89TYR A 108PHE A 109PHE A 112PHE A 182LYS A 191GLN A 194THR A 195ILE A 198TRP A 248TYR A 251LEU A 255THR A 259MET A 279GLU A 283THR A 284MET A 287 |
MRV A1101
|
4MBS_B_MRVB1101 |
4mbs |
MRV DB04835(Maraviroc) |
Clostridiumpasteurianum;Homo sapiens |
CHIMERA PROTEIN OFC-C CHEMOKINERECEPTOR TYPE 5 ANDRUBREDOXIN |
no annotation |
17 |
TYR B 37TRP B 86TYR B 89TYR B 108PHE B 109PHE B 112PHE B 182LYS B 191THR B 195ILE B 198TRP B 248TYR B 251LEU B 255THR B 259GLU B 283THR B 284MET B 287 |
MRV B1101
|
4NC3_A_ERMA1202 |
4nc3 |
ERM DB00696(Ergotamine) |
Escherichia coli;Homo sapiens |
CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 |
PF00001(7tm_1)PF07361(Cytochrom_B562) |
18 |
LEU A 132ASP A 135VAL A 136SER A 139THR A 140VAL A 208LEU A 209PHE A 217MET A 218ALA A 225TRP A 337PHE A 340ASN A 344LEU A 347GLN A 359LEU A 362GLU A 363VAL A 366 |
ERM A1202
|
4NTX_A_AMRA509 |
4ntx |
AMR DB00594(Amiloride) |
Gallus gallus;Micrurus tener |
ACID-SENSING IONCHANNEL 1;BASIC PHOSPHOLIPASEA2 HOMOLOG TX-BETA |
PF00068(Phospholip_A2_1)PF00858(ASC) |
6 |
ASN C 83ARG C 87GLU A 236ASP A 238ASP A 350GLU A 354 |
AMR A 509
|
4ODR_A_FK5A201 |
4odr |
FK5 DB00864(Tacrolimus) |
Homo sapiens;Thermusthermophilus |
PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA |
PF00254(FKBP_C)no annotation |
12 |
TYR A 13LEU A 15ASP A 23LEU A 27LEU A 36ILE A 37LEU A 40TYR A 63ILE A 71ILE A 72PHE A 80PRO B 102 |
FK5 A 201
|
4ODR_B_FK5B201 |
4odr |
FK5 DB00864(Tacrolimus) |
Homo sapiens;Thermusthermophilus |
PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA |
PF00254(FKBP_C)no annotation |
11 |
TYR B 13LEU B 15ASP B 23LEU B 27LEU B 36ILE B 37LEU B 40TYR B 63ILE B 71PHE B 80PRO A 102 |
FK5 B 201
|
4S0V_A_SUVA2001 |
4s0v |
SUV DB09034(Suvorexant) |
Homo sapiens;Pyrococcus abyssi |
HUMAN OREXINRECEPTOR TYPE 2FUSION PROTEIN TO P.ABYSII GLYCOGENSYNTHASE |
PF00001(7tm_1)PF00534(Glycos_transf_1) |
17 |
THR A 111VAL A 114TRP A 120ILE A 130PRO A 131GLN A 134THR A 135VAL A 138GLN A 187GLU A 212HIS A 224TYR A 317ILE A 320ASN A 324HIS A 350VAL A 353TYR A 354 |
SUV A2001
|
4U14_A_0HKA2000 |
4u14 |
0HK DB01409(Tiotropium) |
Escherichia virusT4;Rattus norvegicus |
MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3 |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
16 |
ILE A 116ASP A 147TYR A 148SER A 151ASN A 152TRP A 199LEU A 225THR A 231ALA A 235ALA A 238PHE A 239TRP A 503TYR A 506ASN A 507TYR A 529CYS A 532 |
0HK A2000
|
4U15_A_0HKA2001 |
4u15 |
0HK DB01409(Tiotropium) |
Escherichia virusT4;Rattus norvegicus |
MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
15 |
ASP A 147TYR A 148SER A 151ASN A 152TRP A 199THR A 231THR A 234ALA A 235ALA A 238PHE A 239TRP A 503TYR A 506ASN A 507TYR A 529CYS A 532 |
0HK A2001
|
4U15_B_0HKB1201 |
4u15 |
0HK DB01409(Tiotropium) |
Escherichia virusT4;Rattus norvegicus |
MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 |
no annotation |
16 |
ASP B 147TYR B 148SER B 151ASN B 152TRP B 199LEU B 225THR B 231THR B 234ALA B 235ALA B 238PHE B 239TRP B 503TYR B 506ASN B 507TYR B 529CYS B 532 |
0HK B1201
|
4Y1D_D_DVAD5 |
4y1d |
DVA DB00161(L-Valine) |
Humanimmunodeficiencyvirus 1;syntheticconstruct |
CYCLIC HEXAPEPTIDECYC[NDPOPPKID];INTEGRASE |
NonePF00665(rve) |
3 |
LYS D 1ASN D 4GLU A 170 |
DVA D 5
|
4Z2C_F_MFXF101 |
4z2c |
MFX DB00218(Moxifloxacin) |
Escherichia coli;Streptococcuspneumoniae |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;SYMMETRIZED E-SITEDNA |
PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
4 |
SER B 81ARG C 456GLY C 457GLU C 475 |
MFX F 101
|
4Z2C_H_MFXH101 |
4z2c |
MFX DB00218(Moxifloxacin) |
Escherichia coli;Streptococcuspneumoniae |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;SYMMETRIZED E-SITEDNA |
PF00521(DNA_topoisoIV)no annotation |
4 |
SER A 81ARG D 456GLY D 457GLU D 475 |
MFX H 101
|
4Z2D_F_LFXF102 |
4z2d |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
Escherichia coli;Streptococcuspneumoniae |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;SYMMETRIZED E-SITEDNA |
PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
4 |
SER B 81ARG C 456GLY C 457GLU C 475 |
LFX F 102
|
4Z2D_H_LFXH101 |
4z2d |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
Escherichia coli;Streptococcuspneumoniae |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;SYMMETRIZED E-SITEDNA |
PF00521(DNA_topoisoIV)no annotation |
4 |
SER A 81ARG D 456GLY D 457GLU D 475 |
LFX H 101
|
4Z2E_F_TR6F101 |
4z2e |
TR6 DB00685(Trovafloxacin) |
Escherichia coli;Streptococcuspneumoniae |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;SYMMETRIZED E-SITEDNA |
PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
5 |
SER B 81GLY C 434ARG C 456GLY C 457GLU C 475 |
TR6 F 101
|
4Z2E_H_TR6H101 |
4z2e |
TR6 DB00685(Trovafloxacin) |
Escherichia coli;Streptococcuspneumoniae |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;SYMMETRIZED E-SITEDNA |
PF00521(DNA_topoisoIV)no annotation |
5 |
SER A 81GLY D 434ARG D 456GLY D 457GLU D 475 |
TR6 H 101
|
4Z3O_F_MFXF101 |
4z3o |
MFX DB00218(Moxifloxacin) |
Escherichia coli;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNITB,PARE30-PARC55FUSED TOPO IV FROMS. PNEUMONIAE;E-SITE DNA |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
5 |
ARG B 456GLY B 457GLU B 475SER B1079ARG A1117 |
MFX F 101
|
4Z3O_H_MFXH101 |
4z3o |
MFX DB00218(Moxifloxacin) |
Escherichia coli;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNITB,PARE30-PARC55FUSED TOPO IV FROMS. PNEUMONIAE;E-SITE DNA |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
3 |
ARG A 456GLU A 475SER A1079 |
MFX H 101
|
4Z53_F_TR6F101 |
4z53 |
TR6 DB00685(Trovafloxacin) |
Escherichia coli;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT B,DNATOPOISOMERASE 4SUBUNIT A;E-SITE DNA |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
6 |
GLY A 434ASP A 435ARG A 456GLY A 457SER A1079ARG B1117 |
TR6 F 101
|
4Z53_H_TR6H101 |
4z53 |
TR6 DB00685(Trovafloxacin) |
Escherichia coli;Streptococcuspneumoniae |
DNA TOPOISOMERASE 4SUBUNIT B,DNATOPOISOMERASE 4SUBUNIT A;E-SITE DNA |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
7 |
GLY B 434ASP B 435ARG B 456GLY B 457GLU B 475SER B1079ARG A1117 |
TR6 H 101
|
4ZJ8_A_SUVA2001 |
4zj8 |
SUV DB09034(Suvorexant) |
Homo sapiens;Pyrococcus abyssi |
HUMAN OX1R FUSIONPROTEIN TO P.ABYSIIGLYCOGEN SYNTHASE |
PF00001(7tm_1)PF00534(Glycos_transf_1) |
18 |
ALA A 102SER A 103VAL A 106TRP A 112ILE A 122PRO A 123GLN A 126VAL A 130GLN A 179MET A 183GLU A 204HIS A 216PHE A 219ILE A 314ASN A 318HIS A 344VAL A 347TYR A 348 |
SUV A2001
|
4ZUD_A_OLMA1201 |
4zud |
OLM DB00275(Olmesartan) |
Escherichia coli;Homo sapiens |
CHIMERA PROTEIN OFSOLUBLE CYTOCHROMEB562 AND TYPE-1ANGIOTENSIN IIRECEPTOR |
PF00001(7tm_1)PF07361(Cytochrom_B562) |
9 |
TYR A 35PHE A 77TRP A 84VAL A 108SER A 109LEU A 112ARG A 167ILE A 288TYR A 292 |
OLM A1201
|
5AOX_C_ACTC1001 |
5aox |
ACT DB03166(Aceticacid) |
Homo sapiens;syntheticconstruct |
ALU JO CONSENSUSRNA;SIGNAL RECOGNITIONPARTICLE 14 KDAPROTEIN |
NonePF02290(SRP14) |
3 |
TYR B 27THR B 29THR B 61 |
ACT C1001
|
5AOX_F_ACTF1001 |
5aox |
ACT DB03166(Aceticacid) |
Homo sapiens;syntheticconstruct |
ALU JO CONSENSUSRNA;SIGNAL RECOGNITIONPARTICLE 14 KDAPROTEIN |
None |
3 |
TYR E 27THR E 29THR E 61 |
ACT F1001
|
5B2O_B_ACTB120 |
5b2o |
ACT DB03166(Aceticacid) |
Francisellatularensis;syntheticconstruct |
CRISPR-ASSOCIATEDENDONUCLEASE CAS9;GUIDE RNA |
None |
4 |
ASN A1248SER A1368ARG A1370PRO A1444 |
ACT B 120
|
5B2P_B_ACTB120 |
5b2p |
ACT DB03166(Aceticacid) |
Francisellatularensis;syntheticconstruct |
CRISPR-ASSOCIATEDENDONUCLEASE CAS9;GUIDE RNA |
None |
4 |
ASN A1248SER A1368ARG A1370PRO A1444 |
ACT B 120
|
5BMV_C_VLBC507 |
5bmv |
VLB DB00570(Vinblastine) |
Bos taurus;Sus scrofa |
TUBULIN ALPHA-1BCHAIN;TUBULIN BETA CHAIN |
PF00091(Tubulin)PF03953(Tubulin_C)no annotation |
13 |
LYS B 176ASP B 179TYR B 210PRO B 222TYR B 224LEU B 227PRO C 325VAL C 328ASN C 329ILE C 332PHE C 351VAL C 353ILE C 355 |
VLB C 507
|
5BS8_G_MFXG101 |
5bs8 |
MFX DB00218(Moxifloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC |
PF00521(DNA_topoisoIV)no annotation |
7 |
ALA C 90ARG A 128ASP D 461ARG D 482GLY D 483THR D 500GLU D 501 |
MFX G 101
|
5BS8_H_MFXH101 |
5bs8 |
MFX DB00218(Moxifloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERGGTCATGAATGACTATGCACGTAA |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
7 |
ALA A 90ARG C 128ASP B 461ARG B 482GLY B 483THR B 500GLU B 501 |
MFX H 101
|
5BTA_G_MFXG101 |
5bta |
MFX DB00218(Moxifloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC |
PF00521(DNA_topoisoIV)no annotation |
7 |
SER C 90ARG A 128ASP D 461ARG D 482GLY D 483THR D 500GLU D 501 |
MFX G 101
|
5BTA_H_MFXH101 |
5bta |
MFX DB00218(Moxifloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERGGTCATGAATGACTATGCACGTAA |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
6 |
SER A 90ARG C 128ARG B 482GLY B 483THR B 500GLU B 501 |
MFX H 101
|
5BTC_G_CPFG101 |
5btc |
CPF DB00537(Ciprofloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC |
PF00521(DNA_topoisoIV)no annotation |
6 |
SER C 90ARG A 128ARG D 482GLY D 483THR D 500GLU D 501 |
CPF G 101
|
5BTC_G_CPFG102 |
5btc |
CPF DB00537(Ciprofloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
6 |
SER A 90ARG C 128ARG B 482GLY B 483THR B 500GLU B 501 |
CPF G 102
|
5BTD_E_GFNE101 |
5btd |
GFN DB01044(Gatifloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERGGTCATGAATGACTATGCACGTAA |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
7 |
ALA A 90ARG C 128ASP B 461ARG B 482GLY B 483THR B 500GLU B 501 |
GFN E 101
|
5BTD_G_GFNG101 |
5btd |
GFN DB01044(Gatifloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC |
PF00521(DNA_topoisoIV)no annotation |
7 |
ALA C 90ARG A 128ASP D 461ARG D 482GLY D 483THR D 500GLU D 501 |
GFN G 101
|
5BTF_F_GFNF101 |
5btf |
GFN DB01044(Gatifloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
7 |
SER A 90ARG C 128ASP B 461ARG B 482GLY B 483THR B 500GLU B 501 |
GFN F 101
|
5BTF_G_GFNG101 |
5btf |
GFN DB01044(Gatifloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC |
PF00521(DNA_topoisoIV)no annotation |
7 |
SER C 90ARG A 128ASP D 461ARG D 482GLY D 483THR D 500GLU D 501 |
GFN G 101
|
5BTG_E_LFXE101 |
5btg |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERGGTCATGAATGACTATGCACGTAA |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
6 |
ALA A 90ARG C 128ARG B 482GLY B 483THR B 500GLU B 501 |
LFX E 101
|
5BTG_F_LFXF101 |
5btg |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC |
PF00521(DNA_topoisoIV)no annotation |
7 |
ALA C 90ARG A 128ASP D 461ARG D 482GLY D 483THR D 500GLU D 501 |
LFX F 101
|
5BTI_E_LFXE101 |
5bti |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERGGTCATGAATGACTATGCACGTAA |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
5 |
SER A 90ARG B 482GLY B 483THR B 500GLU B 501 |
LFX E 101
|
5BTI_F_LFXF101 |
5bti |
LFX DB01137(Levofloxacin)DB01165(Ofloxacin) |
Mycobacteriumtuberculosis;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB;DNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC |
no annotation |
5 |
SER C 90ARG D 482GLY D 483THR D 500GLU D 501 |
LFX F 101
|
5CDN_G_EVPG2101 |
5cdn |
EVP DB00773(Etoposide) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
6 |
SER A 84GLU A 88GLY B 436ASP B 437ARG B 458GLY B 459 |
EVP G2101
|
5CDN_N_EVPN2101 |
5cdn |
EVP DB00773(Etoposide) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB |
no annotation |
6 |
SER R 84GLU R 88GLY S 436ASP S 437ARG S 458GLY S 459 |
EVP N2101
|
5CDN_O_EVPO2101 |
5cdn |
EVP DB00773(Etoposide) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB |
no annotation |
6 |
SER C 84GLU C 88GLY D 436ASP D 437ARG D 458GLY D 459 |
EVP O2101
|
5CDN_P_EVPP2101 |
5cdn |
EVP DB00773(Etoposide) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB |
no annotation |
6 |
SER T 84GLU T 88GLY U 436ASP U 437ARG U 458GLY U 459 |
EVP P2101
|
5CDP_H_EVPH2101 |
5cdp |
EVP DB00773(Etoposide) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNIT B |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
6 |
SER A 84GLU A 88GLY B 436ASP B 437ARG B 458GLY B 459 |
EVP H2101
|
5CDQ_E_MFXE2101 |
5cdq |
MFX DB00218(Moxifloxacin) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim)no annotation |
5 |
SER A 84ARG C 122ARG B 458GLY B 459GLU B 477 |
MFX E2101
|
5CDQ_F_MFXF2101 |
5cdq |
MFX DB00218(Moxifloxacin) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB |
PF00521(DNA_topoisoIV)no annotation |
6 |
SER C 84ARG A 122ASP D 437ARG D 458GLY D 459GLU D 477 |
MFX F2101
|
5CDQ_V_MFXV2101 |
5cdq |
MFX DB00218(Moxifloxacin) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB |
no annotation |
5 |
SER R 84ARG T 122ARG S 458GLY S 459GLU S 477 |
MFX V2101
|
5CDQ_W_MFXW2101 |
5cdq |
MFX DB00218(Moxifloxacin) |
Staphylococcusaureus;syntheticconstruct |
DNA GYRASE SUBUNITA;DNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB |
no annotation |
5 |
SER T 84ARG R 122ASP U 437ARG U 458GLU U 477 |
MFX W2101
|
5CXV_A_0HKA501 |
5cxv |
0HK DB01409(Tiotropium) |
Escherichia virusT4;Homo sapiens |
MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1 |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
15 |
ASP A 105TYR A 106SER A 109GLN A 110TRP A 157THR A 189THR A 192ALA A 193ALA A 196PHE A 197TRP A 378TYR A 381ASN A 382TYR A 404CYS A 407 |
0HK A 501
|
5DSG_A_0HKA1201 |
5dsg |
0HK DB01409(Tiotropium) |
Escherichia virusT4;Homo sapiens |
MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4 |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
15 |
ASP A 112TYR A 113SER A 116ASN A 117TRP A 164LEU A 190THR A 196THR A 199ALA A 203PHE A 204TRP A 413TYR A 416ASN A 417TYR A 439CYS A 442 |
0HK A1201
|
5DSG_B_0HKB1201 |
5dsg |
0HK DB01409(Tiotropium) |
Escherichia virusT4;Homo sapiens |
MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4 |
no annotation |
15 |
ASP B 112TYR B 113SER B 116ASN B 117TRP B 164LEU B 190THR B 196THR B 199ALA B 203PHE B 204TRP B 413TYR B 416ASN B 417TYR B 439CYS B 442 |
0HK B1201
|
5DZK_1_BEZ1801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1;ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
None |
3 |
ILE M 71PHE F 147LEU 1 802 |
BEZ 1 801
|
5DZK_2_BEZ2801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1;BEZ-LEU-LEU |
None |
4 |
ILE N 71ARG M 119ILE N 146LEU 2 802 |
BEZ 2 801
|
5DZK_3_BEZ3801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1;BEZ-LEU-LEU |
None |
4 |
ILE m 71GLY m 127ILE m 146LEU 3 802 |
BEZ 3 801
|
5DZK_4_BEZ4801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1;ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
None |
5 |
ILE n 71ARG m 119ILE n 146PHE g 147LEU 4 802 |
BEZ 4 801
|
5DZK_O_BEZO801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
NonePF00574(CLP_protease) |
6 |
PHE a 83SER a 110HIS a 135PRO a 137MET a 164LEU o 802 |
BEZ o 801
|
5DZK_P_BEZP801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
None |
6 |
PHE B 83SER B 110ALA B 111HIS B 135MET B 164LEU P 802 |
BEZ P 801
|
5DZK_Q_BEZQ801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
None |
5 |
SER c 110ALA c 111HIS c 135MET c 164LEU q 802 |
BEZ q 801
|
5DZK_R_BEZR801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
None |
8 |
PHE d 83SER d 110ALA d 111HIS d 135PRO d 137MET d 164LEU r 802LEU r 803 |
BEZ r 801
|
5DZK_S_BEZS801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
None |
6 |
PHE e 83SER e 110HIS e 135MET e 164LEU s 802LEU s 803 |
BEZ s 801
|
5DZK_T_BEZT801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
None |
8 |
PHE F 83SER F 110ALA F 111HIS F 135PRO F 137MET F 164LEU T 802LEU T 803 |
BEZ T 801
|
5DZK_U_BEZU801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
None |
6 |
PHE g 83SER g 110ALA g 111HIS g 135MET g 164LEU u 802 |
BEZ u 801
|
5DZK_V_BEZV801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1;BEZ-LEU-LEU |
NonePF00574(CLP_protease) |
4 |
ILE h 71ARG n 119ILE h 146LEU v 802 |
BEZ v 801
|
5DZK_W_BEZW801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1;ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
None |
5 |
ILE I 71GLY I 127ILE I 146PHE B 147LEU W 802 |
BEZ W 801
|
5DZK_X_BEZX801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1;BEZ-LEU-LEU |
None |
5 |
ILE j 71ARG i 119GLY j 127ILE j 146LEU x 802 |
BEZ x 801
|
5DZK_Y_BEZY801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1;ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2;BEZ-LEU-LEU |
None |
5 |
ILE k 71GLY k 127ILE k 146PHE d 147LEU y 802 |
BEZ y 801
|
5DZK_Z_BEZZ801 |
5dzk |
BEZ DB03793(BenzoicAcid) |
Mycobacteriumtuberculosis;syntheticconstruct |
ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1;BEZ-LEU-LEU |
None |
4 |
ILE l 71GLY l 127ILE l 146LEU z 802 |
BEZ z 801
|
5EU8_B_010B6 |
5eu8 |
010 DB06770(Benzylalcohol) |
Alphacoronavirus1;syntheticconstruct |
N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE;MAIN PROTEASE |
NonePF05409(Peptidase_C30) |
5 |
ASN A 25LEU A 27HIS A 41THR A 47CYS A 144 |
010 B 6
|
5EWJ_B_QELB503 |
5ewj |
QEL DB08954(Ifenprodil) |
Homo sapiens;Xenopus laevis |
GLUTAMATE RECEPTORIONOTROPIC, NMDA 2B;NMDA GLUTAMATERECEPTOR SUBUNIT |
PF01094(ANF_receptor) |
11 |
PRO B 78ALA B 107TYR A 109GLN B 110THR A 110ILE B 111PHE B 114ARG A 115LEU A 135PRO B 177GLU B 236 |
QEL B 503
|
5EWJ_D_QELD503 |
5ewj |
QEL DB08954(Ifenprodil) |
Homo sapiens;Xenopus laevis |
GLUTAMATE RECEPTORIONOTROPIC, NMDA 2B;NMDA GLUTAMATERECEPTOR SUBUNIT |
no annotation |
12 |
PRO D 78ALA D 107TYR C 109GLN D 110THR C 110ILE D 111PHE D 114ARG C 115LEU C 135THR D 174PRO D 177GLU D 236 |
QEL D 503
|
5FLC_C_RAPC999 |
5flc |
RAP DB00877(Sirolimus) |
Homo sapiens;Spodopterafrugiperda |
FKBP;SERINE/THREONINE-PROTEIN KINASE MTOR |
PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08771(FRB_dom)no annotation |
8 |
GLU B2032SER B2035PHE B2039GLY B2040THR B2098TRP B2101TYR B2105PHE B2108 |
RAP C 999
|
5FLC_G_RAPG999 |
5flc |
RAP DB00877(Sirolimus) |
Homo sapiens;Spodopterafrugiperda |
FKBP;SERINE/THREONINE-PROTEIN KINASE MTOR |
no annotation |
8 |
GLU F2032SER F2035PHE F2039GLY F2040THR F2098TRP F2101TYR F2105PHE F2108 |
RAP G 999
|
5GWK_D_EVPD102 |
5gwk |
EVP DB00773(Etoposide) |
Homo sapiens;syntheticconstruct |
DNA TOPOISOMERASE2-ALPHA |
no annotation |
4 |
GLY B 462ASP B 463ARG B 487MET B 766 |
EVP D 102
|
5GWK_F_EVPF102 |
5gwk |
EVP DB00773(Etoposide) |
Homo sapiens;syntheticconstruct |
DNA TOPOISOMERASE2-ALPHA |
PF00521(DNA_topoisoIV)PF01751(Toprim)PF16898(TOPRIM_C)no annotation |
5 |
GLY A 462ASP A 463ARG A 487MET A 762MET A 766 |
EVP F 102
|
5GWY_E_010E6 |
5gwy |
010 DB06770(Benzylalcohol) |
Human coronavirusNL63;syntheticconstruct |
N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE;MAIN PROTEASE |
NonePF05409(Peptidase_C30) |
4 |
THR A 25LEU A 27HIS A 41GLY A 142 |
010 E 6
|
5GWZ_D_010D6 |
5gwz |
010 DB06770(Benzylalcohol) |
Porcine epidemicdiarrhea virus;syntheticconstruct |
N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE;PEDV MAIN PROTEASE |
None |
3 |
MET B 25HIS B 41GLY B 142 |
010 D 6
|
5I1N_F_DVAF9 |
5i1n |
DVA DB00161(L-Valine) |
Gallus gallus;syntheticconstruct |
D-VILLIN HEADPIECESUBDOMAIN;VILLIN-1 |
None |
3 |
ALA C 16ASN C 19LEU C 20 |
DVA F 9
|
5I1N_G_DVAG9 |
5i1n |
DVA DB00161(L-Valine) |
Gallus gallus;syntheticconstruct |
D-VILLIN HEADPIECESUBDOMAIN;VILLIN-1 |
None |
3 |
ALA B 16ASN B 19LEU B 20 |
DVA G 9
|
5I1O_F_DVAF9 |
5i1o |
DVA DB00161(L-Valine) |
Gallus gallus;syntheticconstruct |
D-VILLIN HEADPIECESUBDOMAIN;VILLIN-1 |
None |
3 |
ALA C 16ASN C 19LEU C 20 |
DVA F 9
|
5I1O_H_DVAH9 |
5i1o |
DVA DB00161(L-Valine) |
Gallus gallus;syntheticconstruct |
D-VILLIN HEADPIECESUBDOMAIN;VILLIN-1 |
NonePF02209(VHP) |
3 |
ALA A 16ASN A 19LEU A 20 |
DVA H 9
|
5I1P_F_DVAF9 |
5i1p |
DVA DB00161(L-Valine) |
Gallus gallus;syntheticconstruct |
D-VILLIN HEADPIECESUBDOMAIN;VILLIN-1 |
NonePF02209(VHP) |
3 |
ALA A 16ASN A 19LEU A 20 |
DVA F 9
|
5I1P_G_DVAG9 |
5i1p |
DVA DB00161(L-Valine) |
Gallus gallus;syntheticconstruct |
D-VILLIN HEADPIECESUBDOMAIN;VILLIN-1 |
None |
3 |
ALA D 16ASN D 19LEU D 20 |
DVA G 9
|
5ICX_E_SC2E1 |
5icx |
SC2 DB06151(Acetylcysteine) |
Homo sapiens;Mus musculus;syntheticconstruct |
CETUXIMAB FAB LIGHTCHAIN;MEDITOPE |
PF07654(C1-set)PF07686(V-set)no annotation |
3 |
GLN E 2VAL A 9CYS E 12 |
SC2 E 1
|
5ICX_F_SC2F1 |
5icx |
SC2 DB06151(Acetylcysteine) |
Homo sapiens;Mus musculus;syntheticconstruct |
CETUXIMAB FAB LIGHTCHAIN;MEDITOPE |
no annotation |
3 |
GLN F 2VAL C 9CYS F 12 |
SC2 F 1
|
5INZ_D_DVAD15 |
5inz |
DVA DB00161(L-Valine) |
Papio anubis;syntheticconstruct |
THETA DEFENSIN-2,D-PEPTIDE;THETA DEFENSIN-2,L-PEPTIDE |
None |
3 |
GLY B 1CYS B 3CYS B 16 |
DVA D 15
|
5INZ_D_DVAD2 |
5inz |
DVA DB00161(L-Valine) |
Papio anubis;syntheticconstruct |
THETA DEFENSIN-2,D-PEPTIDE;THETA DEFENSIN-2,L-PEPTIDE |
None |
4 |
GLY D 1GLY A 10CYS A 12ARG C 18 |
DVA D 2
|
5IZF_E_AZ1E2 |
5izf |
AZ1 DB00548(AzelaicAcid) |
Homo sapiens;syntheticconstruct |
6J9-ZEU-DAR-ACA-DAR-NH2;CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA |
PF00069(Pkinase)no annotation |
7 |
GLY A 50GLY A 52SER A 53PHE A 54LYS A 72LEU A 74GLU A 127 |
AZ1 E 2
|
5KKL_B_SAMB8009 |
5kkl |
SAM DB00118(S-Adenosylmethionine) |
Homo sapiens;Chaetomiumthermophilum |
PUTATIVEUNCHARACTERIZEDPROTEIN,HISTONE H3.1PEPTIDE,ZINC FINGERDOMAIN-CONTAININGPROTEIN |
PF00856(VEFS-Box)PF09733(SET) |
13 |
LEU B 804CYS B 807GLY B 808TYR B 809LYS B 852TYR B 855TYR B 878ASN B 880HIS B 881TYR B 918PHE B 922LEU B 925MET B2027 |
SAM B8009
|
5L5F_K_BO2K301 |
5l5f |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
PF00227(Proteasome) |
9 |
THR K 1SER K 21SER K 27VAL K 31LYS K 33MET K 45ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
5L5F_Y_BO2Y301 |
5l5f |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
no annotation |
8 |
THR Y 1SER Y 21SER Y 27LYS Y 33MET Y 45ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
5L5Z_K_BO2K301 |
5l5z |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-5,PROTEASOMESUBUNIT BETA TYPE-5;PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 22ALA K 27LYS K 33GLY K 47ALA K 49ASP L 126 |
BO2 K 301
|
5L5Z_Y_BO2Y301 |
5l5z |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-5,PROTEASOMESUBUNIT BETA TYPE-5;PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6 |
no annotation |
9 |
THR Y 1ALA Y 20THR Y 21ALA Y 22ALA Y 27LYS Y 33GLY Y 47ALA Y 49ASP Z 126 |
BO2 Y 301
|
5L66_K_BO2K301 |
5l66 |
BO2 DB00188(Bortezomib) |
Mus musculus;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
PF00227(Proteasome) |
10 |
THR K 1ALA K 20THR K 21SER K 27LYS K 33MET K 45GLY K 47ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
5L66_Y_BO2Y301 |
5l66 |
BO2 DB00188(Bortezomib) |
Mus musculus;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21SER Y 27LYS Y 33MET Y 45GLY Y 47ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
5L7I_A_VISA1202 |
5l7i |
VIS DB08828(Vismodegib) |
Escherichia coli;Homo sapiens |
SMOOTHENEDHOMOLOG,SOLUBLECYTOCHROMEB562,SMOOTHENEDHOMOLOG |
PF01392(Fz)PF01534(Frizzled)PF07361(Cytochrom_B562) |
14 |
ASN A 219LEU A 221TRP A 281ASP A 384VAL A 386SER A 387TYR A 394ARG A 400GLN A 477PHE A 484GLU A 518ASN A 521LEU A 522MET A 525 |
VIS A1202
|
5L7I_B_VISB1202 |
5l7i |
VIS DB08828(Vismodegib) |
Escherichia coli;Homo sapiens |
SMOOTHENEDHOMOLOG,SOLUBLECYTOCHROMEB562,SMOOTHENEDHOMOLOG |
no annotation |
14 |
LEU B 221TRP B 281ASP B 384SER B 387TYR B 394ARG B 400ASP B 473GLN B 477TRP B 480PRO B 513GLU B 518ASN B 521LEU B 522MET B 525 |
VIS B1202
|
5LAK_I_BEZI1 |
5lak |
BEZ DB03793(BenzoicAcid) |
Alphamesonivirus1;syntheticconstruct |
3CL PROTEASE;BEZ-TYR-TYR-ASN-ECCPEPTIDE INHIBITOR |
NonePF17222(Peptidase_C107) |
3 |
TYR I 2TYR I 3SER A 172 |
BEZ I 1
|
5LAK_J_BEZJ1 |
5lak |
BEZ DB03793(BenzoicAcid) |
Alphamesonivirus1;syntheticconstruct |
3CL PROTEASE;BEZ-TYR-TYR-ASN-ECCPEPTIDE INHIBITOR |
None |
3 |
TYR J 2TYR J 3SER C 172 |
BEZ J 1
|
5MIO_B_LOCB502 |
5mio |
LOC DB01394(Colchicine) |
Bos taurus;Ovis aries |
TUBULIN ALPHA-1BCHAIN;TUBULIN BETA CHAIN |
PF00091(Tubulin)PF03953(Tubulin_C) |
15 |
ALA A 180VAL A 181CYS B 241LEU B 242LEU B 248ALA B 250LYS B 254LEU B 255ASN B 258MET B 259THR B 314ALA B 316ILE B 318LYS B 352ILE B 378 |
LOC B 502
|
5MZJ_A_TEPA2401 |
5mzj |
TEP DB00277(Theophylline) |
Escherichia coli;Homo sapiens |
ADENOSINE RECEPTORA2A,SOLUBLECYTOCHROMEB562,ADENOSINERECEPTOR A2A |
PF00001(7tm_1)PF07361(Cytochrom_B562) |
8 |
LEU A 85PHE A 168GLU A 169MET A 177LEU A 249ASN A 253MET A 270ILE A 274 |
TEP A2401
|
5MZP_A_CFFA2401 |
5mzp |
CFF DB00201(Caffeine) |
Escherichia coli;Homo sapiens |
ADENOSINE RECEPTORA2A,SOLUBLECYTOCHROMEB562,ADENOSINERECEPTOR A2A |
PF00001(7tm_1)PF07361(Cytochrom_B562) |
9 |
ILE A 66VAL A 84PHE A 168GLU A 169MET A 177LEU A 249ASN A 253MET A 270ILE A 274 |
CFF A2401
|
5N8J_E_DVAE7 |
5n8j |
DVA DB00161(L-Valine) |
Streptomycesavidinii;syntheticconstruct |
GLY-DTY-GLY-DLE-DAL-DSG-DVA-DAS-DGL-DSN-DSN-GLY;STREPTAVIDIN |
None |
3 |
TYR B 43SER B 45TRP B 79 |
DVA E 7
|
5N8J_O_DVAO7 |
5n8j |
DVA DB00161(L-Valine) |
Streptomycesavidinii;syntheticconstruct |
GLY-DTY-GLY-DLE-DAL-DSG-DVA-DAS-DGL-DSN-DSN-GLY;STREPTAVIDIN |
NonePF01382(Avidin) |
3 |
TYR A 43SER A 45TRP A 79 |
DVA O 7
|
5N8J_P_DVAP5 |
5n8j |
DVA DB00161(L-Valine) |
Streptomycesavidinii;syntheticconstruct |
GLY-DTY-GLY-DLE-DAL-DSG-DVA-DAS-DGL-DSN-DSN-GLY;STREPTAVIDIN |
None |
3 |
TYR D 43SER D 45TRP D 79 |
DVA P 5
|
5NDV_1_PAR13407 |
5ndv |
PAR DB01421(Paromomycin) |
;Saccharomycescerevisiae |
;25S RIBOSOMAL RNA |
no annotation |
4 |
ASNQ0 119GLUM0 150ARGM0 153ARGM0 154 |
PAR 13407
|
5NDV_1_PAR13424 |
5ndv |
PAR DB01421(Paromomycin) |
;Saccharomycescerevisiae |
;18S RIBOSOMAL RNA;25S RIBOSOMAL RNA |
no annotation |
3 |
ARGM9 64SERN2 72LYSN2 74 |
PAR 13424
|
5NDV_5_PAR53404 |
5ndv |
PAR DB01421(Paromomycin) |
;Saccharomycescerevisiae |
;18S RIBOSOMAL RNA;25S RIBOSOMAL RNA |
no annotation |
3 |
ARGm9 64SERn2 72LYSn2 74 |
PAR 53404
|
5NDV_8_PAR8202 |
5ndv |
PAR DB01421(Paromomycin) |
;Saccharomycescerevisiae |
;5.8S RIBOSOMAL RNA;5S RIBOSOMAL RNA |
no annotation |
3 |
GLNo9 19ARGo7 24ASNo9 50 |
PAR 8 202
|
5NWU_A_ACAA18 |
5nwu |
ACA DB00513(AminocaproicAcid) |
Humanimmunodeficiencyvirus 1;unidentified |
WTFP-TAG,GP41 |
no annotation |
15 |
ALA A 13GLY A 14SER A 15LYS A 16LYS A 17LYS A 19ASN A 20GLU A 21GLN A 22GLU A 23LEU A 24LEU A 25GLU A 26LEU A 27TRP A 30 |
ACA A 18
|
5O45_B_CCSB13 |
5o45 |
CCS DB04339(Carbocisteine) |
Homo sapiens;syntheticconstruct |
PHE-MEA-9KK-SAR-ASP-VAL-MEA-TYR-SAR-TRP-TYR-LEU-CCS-GLY-NH2;PROGRAMMED CELLDEATH 1 LIGAND 1 |
NonePF07686(V-set) |
9 |
PHE B 1TYR B 11LEU B 12GLY B 14TYR A 56GLU A 58ASP A 61ASN A 63VAL A 76 |
CCS B 13
|
5O4Y_D_CCSD14 |
5o4y |
CCS DB04339(Carbocisteine) |
Homo sapiens;syntheticconstruct |
PHE-MAA-ASN-PRO-HIS-LEU-SER-TRP-SER-TRP-9KK-9KK-ARG-CCS-GLY-NH2;PROGRAMMED CELLDEATH 1 LIGAND 1 |
None |
12 |
PHE D 1LEU D 6TRP D 8SER D 9ARG D 13GLY D 15GLU E 60GLY E 110VAL E 111ARG E 125THR E 127LYS E 129 |
CCS D 14
|
5SYO_C_C5EC301 |
5syo |
C5E DB09028(Cytisine) |
Aplysiacalifornica;Homo sapiens |
SOLUBLEACETYLCHOLINERECEPTOR, NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-3 CHIMERA |
None |
10 |
TRP B 55TYR C 93MET B 116ILE B 118TRP C 147VAL C 148TYR C 188CYS C 190CYS C 191TYR C 195 |
C5E C 301
|
5SYO_E_C5EE301 |
5syo |
C5E DB09028(Cytisine) |
Aplysiacalifornica;Homo sapiens |
SOLUBLEACETYLCHOLINERECEPTOR, NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-3 CHIMERA |
None |
10 |
TRP D 55TYR E 93MET D 116ILE D 118TRP E 147VAL E 148TYR E 188CYS E 190CYS E 191TYR E 195 |
C5E E 301
|
5TUD_A_ERMA2001 |
5tud |
ERM DB00696(Ergotamine) |
Escherichia coli;Homo sapiens |
5-HYDROXYTRYPTAMINERECEPTOR 2B,SOLUBLECYTOCHROME B562CHIMERA |
PF00001(7tm_1)PF07361(Cytochrom_B562) |
19 |
LEU A 132ASP A 135VAL A 136SER A 139THR A 140VAL A 208LEU A 209LYS A 211MET A 218ALA A 225PHE A 340PHE A 341ASN A 344LEU A 347VAL A 348GLN A 359LEU A 362GLU A 363VAL A 366 |
ERM A2001
|
5TUD_D_ERMD1201 |
5tud |
ERM DB00696(Ergotamine) |
Escherichia coli;Homo sapiens |
5-HYDROXYTRYPTAMINERECEPTOR 2B,SOLUBLECYTOCHROME B562CHIMERA |
no annotation |
18 |
LEU D 132ASP D 135VAL D 136SER D 139THR D 140VAL D 208LEU D 209MET D 218ALA D 225PHE D 340PHE D 341ASN D 344LEU D 347VAL D 348GLN D 359LEU D 362GLU D 363VAL D 366 |
ERM D1201
|
5UIG_A_EDTA501 |
5uig |
EDT DB00974(EdeticAcid) |
Escherichia coli;Homo sapiens |
ADENOSINE RECEPTORA2A,SOLUBLECYTOCHROMEB562,ADENOSINERECEPTOR A2A |
PF00001(Cytochrom_B562)PF07361(7tm_1) |
6 |
ASN A 39THR A 41ASN A 42ARG A 102ILE A 292GLU A 294 |
EDT A 501
|
5WEO_A_CYZA1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd)no annotation |
10 |
ILE D 481PRO A 494PRO D 494MET A 496SER A 497SER D 497SER D 729GLY D 731ASP A 760LYS A 763 |
CYZ A1302
|
5WEO_B_CYZB1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
no annotation |
9 |
ILE C 481PRO C 494PRO B 494MET B 496SER B 497SER C 729GLY C 731ASP B 760LYS B 763 |
CYZ B1302
|
5WEO_C_CYZC1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
no annotation |
9 |
PRO C 494PRO B 494MET C 496SER B 497SER C 497SER B 729GLY B 731ASP C 760LYS C 763 |
CYZ C1302
|
5WEO_D_CYZD1302 |
5weo |
CYZ DB00606(Cyclothiazide) |
Mus musculus;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNITCHIMERA |
PF00060(Lig_chan)PF00822(PMP22_Claudin)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd)no annotation |
9 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729GLY A 731ASP D 760LYS D 763 |
CYZ D1302
|
5XPR_A_K86A1201 |
5xpr |
K86 DB00559(Bosentan) |
Escherichia virusT4;Homo sapiens |
ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
16 |
HIS A 150ASP A 154PRO A 178GLN A 181LYS A 182VAL A 185GLU A 236LYS A 273LEU A 277TYR A 281TRP A 336LEU A 339HIS A 340ARG A 343ILE A 372ALA A 375 |
K86 A1201
|
5ZMQ_I_PACI1 |
5zmq |
PAC DB09269(Phenylaceticacid) |
Zika virus;syntheticconstruct |
SERINE PROTEASE NS3;SERINE PROTEASESUBUNIT NS2B;PEPTIDEPAC-DLY-DLY-DAR |
None |
3 |
GLU E 66VAL D 155TYR D 161 |
PAC I 1
|
5ZMQ_K_PACK1 |
5zmq |
PAC DB09269(Phenylaceticacid) |
Zika virus;syntheticconstruct |
SERINE PROTEASE NS3;PEPTIDEPAC-DLY-DLY-DAR |
None |
3 |
ALA H 132VAL H 155TYR H 161 |
PAC K 1
|
6A93_A_8NUA3001 |
6a93 |
8NU DB00734(Risperidone) |
Escherichia coli;Homo sapiens |
5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562 |
PF00001(7tm_1) |
14 |
SER A 131TRP A 151ASP A 155SER A 159THR A 160ILE A 163LEU A 228PHE A 332TRP A 336PHE A 339PHE A 340LEU A 362ASN A 363TYR A 370 |
8NU A3001
|
6A93_B_8NUB3001 |
6a93 |
8NU DB00734(Risperidone) |
Escherichia coli;Homo sapiens |
5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562 |
None |
17 |
SER B 131TYR B 139TRP B 151ASP B 155VAL B 156SER B 159THR B 160ILE B 163LEU B 228PHE B 332TRP B 336PHE B 339PHE B 340LEU B 362ASN B 363VAL B 366TYR B 370 |
8NU B3001
|
6A94_A_ZOTA3001 |
6a94 |
ZOT DB09225(Zotepine) |
Escherichia coli;Homo sapiens |
5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562 |
PF00001(7tm_1) |
13 |
TRP A 151ASP A 155SER A 159LEU A 229VAL A 235GLY A 238SER A 242PHE A 332TRP A 336PHE A 339PHE A 340ASN A 343VAL A 366 |
ZOT A3001
|
6A94_B_ZOTB3001 |
6a94 |
ZOT DB09225(Zotepine) |
Escherichia coli;Homo sapiens |
5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562 |
None |
13 |
ASP B 155VAL B 156SER B 159THR B 160LEU B 229VAL B 235GLY B 238SER B 242PHE B 332TRP B 336PHE B 339PHE B 340VAL B 366 |
ZOT B3001
|
6AJI_A_AY6A1001 |
6aji |
AY6 DB06155(Rimonabant) |
Mycolicibacteriumsmegmatis;Escherichia virusT4 |
DRUG EXPORTERS OFTHE RNDSUPERFAMILY-LIKEPROTEIN,ENDOLYSIN |
PF00959(MMPL)PF03176(MMPL) |
13 |
VAL A 245LEU A 248ILE A 253ILE A 319VAL A 638LEU A 642ASP A 645TYR A 646PHE A 649LEU A 686VAL A 689ALA A 690LEU A 708 |
AY6 A1001
|
6AK3_A_P2EA1201 |
6ak3 |
P2E DB00917(Dinoprostone) |
Escherichia coli;Homo sapiens |
PROSTAGLANDIN E2RECEPTOR EP3SUBTYPE,SOLUBLECYTOCHROME B562 |
PF00001(7tm_1) |
16 |
PRO A 55MET A 58GLN A 103THR A 106THR A 107VAL A 110TYR A 114MET A 137GLY A 141THR A 206TRP A 207LEU A 329VAL A 332ARG A 333SER A 336GLN A 339 |
P2E A1201
|
6AK3_B_P2EB1201 |
6ak3 |
P2E DB00917(Dinoprostone) |
Escherichia coli;Homo sapiens |
PROSTAGLANDIN E2RECEPTOR EP3SUBTYPE,SOLUBLECYTOCHROME B562 |
None |
17 |
PRO B 55MET B 58GLN B 103THR B 106THR B 107VAL B 110TYR B 114MET B 137GLY B 141THR B 206TRP B 207TRP B 295LEU B 329VAL B 332ARG B 333SER B 336GLN B 339 |
P2E B1201
|
6BQG_A_ERMA1201 |
6bqg |
ERM DB00696(Ergotamine) |
Escherichia coli;Homo sapiens |
5-HYDROXYTRYPTAMINERECEPTOR 2C,SOLUBLECYTOCHROME B562 |
no annotation |
17 |
ASP A 134VAL A 135SER A 138THR A 139VAL A 208LEU A 209VAL A 215GLY A 218ALA A 222PHE A 327ASN A 331SER A 334VAL A 335GLU A 347LEU A 350ASN A 351VAL A 354 |
ERM A1201
|
6CDU_A_EY4A501 |
6cdu |
EY4 DB11371(Alfaxalone) |
Homo sapiens;Dickeya dadantii |
CHIMERIC ALPHA1GABAARECEPTOR |
NonePF02931(Neur_chan_memb)PF02932(Neur_chan_LBD) |
5 |
GLN A 242VAL A 243TRP A 246THR B 306PRO A 401 |
EY4 A 501
|
6CDU_A_EY4A502 |
6cdu |
EY4 DB11371(Alfaxalone) |
Homo sapiens;Dickeya dadantii |
CHIMERIC ALPHA1GABAARECEPTOR |
NonePF02931(Neur_chan_memb)PF02932(Neur_chan_LBD) |
7 |
GLN E 242VAL E 243TRP E 246ALA A 305THR A 306TYR A 309PRO E 401 |
EY4 A 502
|
6CDU_B_EY4B500 |
6cdu |
EY4 DB11371(Alfaxalone) |
Homo sapiens;Dickeya dadantii |
CHIMERIC ALPHA1GABAARECEPTOR |
None |
6 |
GLN B 242VAL B 243TRP B 246ALA C 305THR C 306PRO B 401 |
EY4 B 500
|
6CDU_D_EY4D500 |
6cdu |
EY4 DB11371(Alfaxalone) |
Homo sapiens;Dickeya dadantii |
CHIMERIC ALPHA1GABAARECEPTOR |
None |
7 |
ILE C 239GLN C 242VAL C 243TRP C 246ALA D 305THR D 306PRO C 401 |
EY4 D 500
|
6CDU_E_EY4E500 |
6cdu |
EY4 DB11371(Alfaxalone) |
Homo sapiens;Dickeya dadantii |
CHIMERIC ALPHA1GABAARECEPTOR |
None |
8 |
ILE D 239GLN D 242VAL D 243TRP D 246ALA E 305THR E 306TYR E 309PRO D 401 |
EY4 E 500
|
6CDU_F_EY4F500 |
6cdu |
EY4 DB11371(Alfaxalone) |
Homo sapiens;Dickeya dadantii |
CHIMERIC ALPHA1GABAARECEPTOR |
None |
7 |
ILE J 239GLN J 242VAL J 243TRP J 246ALA F 305THR F 306PRO J 401 |
EY4 F 500
|
6CDU_G_EY4G501 |
6cdu |
EY4 DB11371(Alfaxalone) |
Homo sapiens;Dickeya dadantii |
CHIMERIC ALPHA1GABAARECEPTOR |
None |
7 |
ILE F 239GLN F 242VAL F 243TRP F 246ILE G 302THR G 306PRO F 401 |
EY4 G 501
|
6CDU_G_EY4G502 |
6cdu |
EY4 DB11371(Alfaxalone) |
Homo sapiens;Dickeya dadantii |
CHIMERIC ALPHA1GABAARECEPTOR |
None |
8 |
ILE G 239GLN G 242VAL G 243TRP G 246ILE H 302THR H 306TYR H 309PRO G 401 |
EY4 G 502
|
6CDU_H_EY4H500 |
6cdu |
EY4 DB11371(Alfaxalone) |
Homo sapiens;Dickeya dadantii |
CHIMERIC ALPHA1GABAARECEPTOR |
None |
7 |
GLN H 242VAL H 243TRP H 246ALA I 305THR I 306TYR I 309PRO H 401 |
EY4 H 500
|
6CDU_I_EY4I500 |
6cdu |
EY4 DB11371(Alfaxalone) |
Homo sapiens;Dickeya dadantii |
CHIMERIC ALPHA1GABAARECEPTOR |
None |
5 |
GLN I 242VAL I 243TRP I 246THR J 306PRO I 401 |
EY4 I 500
|
6CHG_C_SAMC1101 |
6chg |
SAM DB00118(S-Adenosylmethionine) |
Homo sapiens;Kluyveromyceslactis |
H3;HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-4 SPECIFIC |
NonePF00856(SET) |
14 |
MET J 4ILE C 867HIS C 868ASN C 869TRP C 870SER C 911SER C 912TYR C 913PHE C 934ASN C 936HIS C 937TYR C 974LEU C 989LEU C 999 |
SAM C1101
|
6CM4_A_8NUA2001 |
6cm4 |
8NU DB00734(Risperidone) |
Homo sapiens;Escherichia virusT4 |
D(2) DOPAMINERECEPTOR, ENDOLYSINCHIMERA |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
16 |
TRP A 100PHE A 110ASP A 114VAL A 115CYS A 118THR A 119ALA A 122SER A 193SER A 197PHE A 382TRP A 386PHE A 389PHE A 390TYR A 408THR A 412TYR A 416 |
8NU A2001
|
6DLZ_A_CYZA1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
10 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729GLY D 731LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DLZ_B_CYZB1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DLZ_C_CYZC1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729GLY B 731LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DLZ_D_CYZD1302 |
6dlz |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
11 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM0_A_CYZA1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan-Glu_bd)PF01094(Lig_chan)PF10613(ANF_receptor) |
9 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM0_B_CYZB1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729GLY C 731LEU B 751LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM0_C_CYZC1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
9 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM0_D_CYZD1302 |
6dm0 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan-Glu_bd)PF01094(Lig_chan)PF10613(ANF_receptor) |
9 |
PRO A 494MET D 496SER D 497SER A 729GLY A 731LEU D 751LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM1_A_CYZA1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(ANF_receptor)PF00822(Lig_chan)PF01094(Lig_chan-Glu_bd)PF10613(PMP22_Claudin) |
10 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729GLY D 731LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM1_B_CYZB1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM1_C_CYZC1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729GLY B 731LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM1_D_CYZD1302 |
6dm1 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(ANF_receptor)PF00822(Lig_chan)PF01094(Lig_chan-Glu_bd)PF10613(PMP22_Claudin) |
11 |
ILE A 481PRO A 494PRO D 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DM2_A_CYZA1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
9 |
ILE D 481PRO A 494MET A 496SER A 497SER D 729LEU A 751SER A 754ASP A 760LYS A 763 |
CYZ A1302
|
6DM2_B_CYZB1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
10 |
ILE C 481PRO C 494MET B 496SER B 497SER C 729LEU B 751SER B 754LEU B 759ASP B 760LYS B 763 |
CYZ B1302
|
6DM2_C_CYZC1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
None |
9 |
ILE B 481PRO C 494MET C 496SER C 497SER B 729LEU C 751SER C 754ASP C 760LYS C 763 |
CYZ C1302
|
6DM2_D_CYZD1302 |
6dm2 |
CYZ DB00606(Cyclothiazide) |
Homo sapiens;Rattus norvegicus |
GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT |
NonePF00060(PMP22_Claudin)PF00822(Lig_chan)PF01094(ANF_receptor)PF10613(Lig_chan-Glu_bd) |
10 |
ILE A 481PRO A 494MET D 496SER D 497SER A 729LEU D 751SER D 754LEU D 759ASP D 760LYS D 763 |
CYZ D1302
|
6DRX_A_H8GA1201 |
6drx |
H8G DB00589(Lisuride) |
Escherichia coli;Homo sapiens |
5HT2B RECEPTOR, BRILCHIMERA |
PF00001(Cytochrom_B562)PF07361(7tm_1) |
13 |
TRP A 131LEU A 132ASP A 135VAL A 136SER A 139THR A 140PHE A 217ALA A 225TRP A 337PHE A 340ASN A 344VAL A 366TYR A 370 |
H8G A1201
|
6DRY_A_H8DA2001 |
6dry |
H8D DB00353(Methylergometrine) |
Escherichia coli;Homo sapiens |
5HT2B RECEPTOR, BRILCHIMERA |
PF00001(Cytochrom_B562)PF07361(7tm_1) |
11 |
ASP A 135VAL A 136SER A 139THR A 140VAL A 208LEU A 209ALA A 225PHE A 340GLN A 359VAL A 366TYR A 370 |
H8D A2001
|
6DRZ_A_H8JA1206 |
6drz |
H8J DB00247(Methysergide) |
Escherichia coli;Homo sapiens |
5HT2B RECEPTOR, BRILCHIMERA |
PF00001(Cytochrom_B562)PF07361(7tm_1) |
13 |
ASP A 135VAL A 136SER A 139THR A 140VAL A 208LEU A 209PHE A 217GLY A 225PHE A 340PHE A 341ASN A 344VAL A 366TYR A 370 |
H8J A1206
|
6ECE_C_DVAC3010 |
6ece |
DVA DB00161(L-Valine) |
Streptomycestsusimaensis;syntheticconstruct |
VLM2;DODECADEPSIPEPTIDE |
NonePF00975(Thioesterase) |
3 |
ALA A2501PHE A2513GLN A2568 |
DVA C3010
|
6ECF_I_DVAI3010 |
6ecf |
DVA DB00161(L-Valine) |
Streptomycestsusimaensis;syntheticconstruct |
VLM2;DODECADEPSIPEPTIDE |
None |
3 |
PHE B2513ARG B2545ALA B2626 |
DVA I3010
|
6G9I_B_CXXB707 |
6g9i |
CXX DB01242(Clomipramine) |
Humanimmunodeficiencyvirus 1;Zaire ebolavirus |
ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN |
no annotation |
7 |
ILE A 38LEU A 43VAL A 66LEU A 184LEU A 186MET B 548LEU B 558 |
CXX B 707
|
6HLO_A_GBQA1501 |
6hlo |
GBQ DB00673(Aprepitant) |
Homo sapiens;Pyrococcus abyssi |
SUBSTANCE-PRECEPTOR,GLGAGLYCOGENSYNTHASE,SUBSTANCE-PRECEPTOR |
PF00001(7tm_1)PF00534(Glycos_transf_1) |
21 |
MET A 81ASN A 89ASN A 109PRO A 112ILE A 113ILE A 116GLN A 165ILE A 182TRP A 184GLU A 193TYR A 196HIS A 197VAL A 200THR A 201ILE A 204TRP A 261PHE A 264HIS A 265PHE A 268MET A 291MET A 295 |
GBQ A1501
|
6HLP_A_GAWA1501 |
6hlp |
GAW DB09048(Netupitant) |
Homo sapiens;Pyrococcus abyssi |
SUBSTANCE-PRECEPTOR,SUBSTANCE-PRECEPTOR |
PF00001(7tm_1)PF00534(Glycos_transf_1) |
17 |
ASN A 89ASN A 109PRO A 112ILE A 113ILE A 116GLN A 165HIS A 197VAL A 200THR A 201ILE A 204TRP A 261PHE A 264HIS A 265PHE A 268PRO A 271TYR A 272MET A 295 |
GAW A1501
|
6HUO_D_08HD501 |
6huo |
08H DB00404(Alprazolam) |
Homo sapiens;Homo sapiens;Bos taurus |
GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT ALPHA-1;GAMMA-AMINOBUTYRICACID RECEPTORSUBUNIT GAMMA-2 |
NonePF02931(Neur_chan_LBD)PF02932(Neur_chan_memb) |
8 |
TYR C 58ASN C 60PHE C 77PHE D 100HIS D 102VAL D 203SER D 205TYR D 210 |
08H D 501
|
6HUP_B_DZPB502 |
6hup |
DZP DB00829(Diazepam) |
Homo sapiens;Homo sapiens;Bos taurus |
GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT ALPHA-1;GAMMA-AMINOBUTYRICACID RECEPTORSUBUNIT BETA-3 |
PF02931(Neur_chan_LBD)PF02932(Neur_chan_memb) |
11 |
ILE A 228LEU A 232PRO A 233MET A 236THR A 237MET B 261THR B 262ASN B 265LEU B 285MET B 286PHE B 289 |
DZP B 502
|
6HUP_D_DZPD2001 |
6hup |
DZP DB00829(Diazepam) |
Homo sapiens;Homo sapiens;Bos taurus |
GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT ALPHA-1;GAMMA-AMINOBUTYRICACID RECEPTORSUBUNIT GAMMA-2 |
NonePF02931(Neur_chan_memb)PF02932(Neur_chan_LBD) |
9 |
TYR C 58ASN C 60PHE C 77PHE D 100HIS D 102TYR D 160VAL D 203SER D 205TYR D 210 |
DZP D2001
|
6HUP_E_DZPE502 |
6hup |
DZP DB00829(Diazepam) |
Homo sapiens;Homo sapiens;Bos taurus |
GAMMA-AMINOBUTYRICACID RECEPTORSUBUNITALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTORSUBUNIT ALPHA-1;GAMMA-AMINOBUTYRICACID RECEPTORSUBUNIT BETA-3 |
None |
10 |
LEU D 232PRO D 233MET D 236MET E 261THR E 262ASN E 265LEU D 269LEU E 285MET E 286PHE E 289 |
DZP E 502
|
6IBL_A_H98A501 |
6ibl |
H98 DB01274(Arformoterol) |
Escherichia coli;Meleagrisgallopavo |
THIOREDOXIN 1,BETA-1ADRENERGIC RECEPTOR |
PF00001(Thioredoxin)PF00085(7tm_1) |
16 |
TRP A 117THR A 118ASP A 121VAL A 122VAL A 125ASP A 200PHE A 201SER A 211SER A 215TRP A 303PHE A 306PHE A 307ASN A 310VAL A 326ASN A 329TYR A 333 |
H98 A 501
|
6IBL_B_H98B501 |
6ibl |
H98 DB01274(Arformoterol) |
Escherichia coli;Meleagrisgallopavo |
THIOREDOXIN 1,BETA-1ADRENERGIC RECEPTOR |
None |
16 |
TRP B 117THR B 118ASP B 121VAL B 122VAL B 125ASP B 200PHE B 201SER B 211SER B 215TRP B 303PHE B 306PHE B 307ASN B 310VAL B 326ASN B 329TYR B 333 |
H98 B 501
|
6J20_A_GBQA1201 |
6j20 |
GBQ DB00673(Aprepitant) |
Homo sapiens;Escherichia virusT4 |
SUBSTANCE-PRECEPTOR,ENDOLYSIN |
PF00001(7tm_1)PF00959(Phage_lysozyme) |
19 |
ASN A 89ASN A 109PRO A 112ILE A 113VAL A 116GLN A 165ILE A 182TRP A 184GLU A 193TYR A 196HIS A 197VAL A 200THR A 201ILE A 204TRP A 261PHE A 264HIS A 265PHE A 268MET A 291 |
GBQ A1201
|
6J21_A_GBQA1201 |
6j21 |
GBQ DB00673(Aprepitant) |
Homo sapiens;Escherichia virusT4 |
SUBSTANCE-PRECEPTOR,ENDOLYSIN |
PF00001(Phage_lysozyme)PF00959(7tm_1) |
16 |
ASN A 89ASN A 109PRO A 112ILE A 113VAL A 116ILE A 182TRP A 184GLU A 193HIS A 197VAL A 200THR A 201TRP A 261PHE A 264HIS A 265PHE A 268MET A 291 |
GBQ A1201
|
6MHT_D_SAMD328 |
6mht |
SAM DB00118(S-Adenosylmethionine) |
;Haemophilushaemolyticus |
CYTOSINE-SPECIFICMETHYLTRANSFERASEHHAI |
NonePF00145(DNA_methylase) |
13 |
PHE A 18GLY A 20LEU A 21GLY A 23ASN A 39GLU A 40TRP A 41ASP A 42ASP A 60ILE A 61ASN A 304SER A 305VAL A 306 |
SAM D 328
|
6MXT_A_K5YA1401 |
6mxt |
K5Y DB00938(Salmeterol) |
Homo sapiens;Escherichia virusT4 |
ENDOLYSIN, BETA-2ADRENERGIC RECEPTORCHIMERA |
PF00001(Phage_lysozyme)PF00959(7tm_1) |
15 |
TRP A1109ASP A1113VAL A1114VAL A1117ASP A1192PHE A1193SER A1203SER A1207PHE A1289ASN A1293HIS A1296TYR A1308ILE A1309ASN A1312TYR A1316 |
K5Y A1401
|